RSS Atom • ISSN 1472-4683 • Subscribe • About
2000
- Tenofovir (PMPA), defining cross-resistance profiles Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Mycophenalate mofetil in patients with advanced disease and multidrug resistant HIV Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Hydroxyurea is active in vitro against multidrug-resistant HIV Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- ABT-378/r (Lopinavir): defining a resistance profile and the effects of resistance on virological response in experienced patients Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- What is the significance of blips in viral load? Conference reports - Treatment strategies - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Phenotypic resistance testing improves response to therapy: final analysis of VIRA3001 Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- A prospective study of strategic treatment interruptions in patients with chronic HIV-infection Conference reports - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Added value of hydroxyurea or IL-2 to STIs remains uncertain Conference reports - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Continued benefits from protease inhibitor based therapy despite virological failure Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Do resistance mutations disappear off therapy? Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Selection of PI mutations during slow decay of VL and resistance after PI failure Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Thymidine analogues mutations (TAMS) and other NA-related resistance mutations Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- A warning on simplification strategies: not suitable for all Conference reports - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Prophylaxis and treatment of malaria in the presence of HIV protease inhibitor therapy On the web - 16 July 2000
- Accelerated replicative senescence of the peripheral immune system induced by HIV infection Basic science and immunology - 16 July 2000
- Gastrostomy tube (G-tube) insertion for improvement of adherence to HAART in pediatric patients with HIV Paediatric care - 16 July 2000
- 3rd report of patient whose NRTI-associated lactic acidosis responded to riboflavin (vitamin B2) Side effects - 16 July 2000
- Immune response may persist after emergence of protease inhibitor-resistant HIV Resistance - 16 July 2000
- Third International Workshop on Salvage Therapy for HIV Infection, April 12-14, 2000, Chicago, USA Conference reports - Conference index - Int Workshop on Salvage Therapy 3rd - 16 June 2000
- Exercise testing in HIV patients with random increased lactic acid levels: evidence for a reduced anaerobic threshold with a pattern of mitochondrial dysfunction Conference reports - Side effects - Int Workshop on Salvage Therapy 3rd - 15 June 2000
- Accelerated bone mineral loss in HIV-positive patients receiving potent antiretroviral therapy Side effects - 15 June 2000
- Antiretroviral therapy improves thymic output in some HIV-infected children Paediatric care - 15 June 2000
- CD8+-cell antiviral factors not restricted to cytotoxic T cells induced during HIV Basic science and immunology - 15 June 2000
- HIV-related anal cancer incidence increased in long-term survivors Opportunistic infections and complications - 15 June 2000
- Third International Workshop on Salvage Therapy for HIV Infection, April 12-14, 2000, Chicago, USA Conference reports - Conference index - Int Workshop on Salvage Therapy 3rd - 15 May 2000
- Clinical studies of indinavir/ritonavir as salvage therapy Conference reports - Resistance - Int Workshop on Salvage Therapy 3rd - 15 May 2000
- Indinavir plus ritonavir: might exposure to higher levels of indinavir overcome protease resistant HIV and prove useful to 'rescue' previously failed protease inhibitor based combinations? Conference reports - Resistance - Int Workshop on Salvage Therapy 3rd - 15 May 2000
- First International Workshop in Clinical Pharmacology in HIV Therapy, 30-31 March 2000, Noordwijk, Netherlands Conference reports - Conference index - PK Workshop 1st 2000 - 15 May 2000
- ATHENA – Early results from first randomised study of clinical benefits of TDM Conference reports - PK Workshop 1st 2000 - 15 May 2000
- TDM for individualising dosing – practicality and efficacy for PIs and RTIs Conference reports - PK Workshop 1st 2000 - 15 May 2000
- Drug interactions: amprenavir, saquinavir, ABT-378/r (lopinavir/r), indinavir, efavirenz, ritonavir Conference reports - PK and drug interactions - PK Workshop 1st 2000 - 15 May 2000
- L-Acetyl Carnitine (LAC) improves symptoms of peripheral neuropathy (PN): evidence for increases in cutaneous innervation Conference reports - Side effects - PK Workshop 1st 2000 - 15 May 2000
- Liquid formulation of efavirenz available for children in the uk on named patient basis Paediatric care - 15 May 2000
- EMEA public statement on Viramune (nevirapine): severe and life-threatening cutaneous and hepatic reactions Treatment alerts - 15 May 2000
- 7th Conference on Retroviruses and Opportunistic Infections (ROI), January 30-February 2 2000, San Francisco Conference reports - Conference index - CROI 7 (Retrovirus) 2000 - 14 April 2000
- Paediatrics: children are not small (or miniature) adults Conference reports - Paediatric care - CROI 7 (Retrovirus) 2000 - 14 April 2000
- HIV-positive women, pregnancy and newborns Conference reports - PMTCT and maternal health - Resistance - CROI 7 (Retrovirus) 2000 - 14 April 2000
- Flu-like symptoms of severe acute HIV infection develop after suspension of HAART Conference reports - CROI 7 (Retrovirus) 2000 - 14 April 2000
- Non-clade B virus: epidemiology, testing strategies and resistance Conference reports - Resistance - CROI 7 (Retrovirus) 2000 - 14 April 2000
- Public Health Service (US) releases updated guidelines for treatment of HIV positive pregnant women Guidelines - 14 April 2000
- French National Drug Agency re-commends use of IL-2 if HAART does not lead to an increase in CD4 count to greater than 200 cells/mm3 Treatment strategies - 14 April 2000
- St John's Wort: message from Professor A Breckenridge, Chair, Committee on Safety of Medicines. PK and drug interactions - Treatment alerts - 14 April 2000
- Interactions of St John's Wort (Hypericum perforatum) preparations PK and drug interactions - 14 April 2000
- Important safety information for people taking St John's Wort preparations PK and drug interactions - 14 April 2000
- French National Drug Agency re-commends use of IL-2 if HAART does not lead to an increase in CD4 count to greater than 200 cells/mm3 Other news - 1 April 2000